Inflammatory Bowel Diseases

Cover image for Inflammatory Bowel Diseases

January 2003

Volume 9, Issue 1

Pages 1–74

  1. Original Contributions

    1. Top of page
    2. Original Contributions
    3. Basic Science Review
    4. Clinical Review
    5. Professional Affairs And Public Policy
    6. Editorial
    7. Selected Summaries
    1. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease (pages 1–9)

      Dr. Mark S. Silverberg, Lucia Mirea, Shelley B. Bull, Janet E. Murphy, A. Hillary Steinhart, Gordon R. Greenberg, Robin S. McLeod, Zane Cohen, Judith A. Wade and Katherine A. Siminovitch

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200301000-00001

    2. The effect of 5-aminosalicylic acid–containing drugs on sulfide production by sulfate-reducing and amino acid–fermenting bacteria (pages 10–17)

      Laurie M. Edmond, Mark J. Hopkins, Elizabeth A. Magee and John H. Cummings

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200301000-00002

    3. Experimental colitis in rats with portal hypertension and liver disease (pages 18–24)

      Dr. Zvi Ackerman, Fanny Karmeli, Patrizia Cohen and Daniel Rachmilewitz

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200301000-00003

    4. Case report: “Popcorn” dystrophic ileal calcification in a patient with Crohn's disease (pages 25–27)

      Devang N. Prajapati, Joseph P. Kim, Kristine S. Spinelli, Gary Sudakoff, Edward T. Stewart, Richard A. Komorowski, Gordon L. Telford and Dr. David G. Binion

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200301000-00004

  2. Basic Science Review

    1. Top of page
    2. Original Contributions
    3. Basic Science Review
    4. Clinical Review
    5. Professional Affairs And Public Policy
    6. Editorial
    7. Selected Summaries
  3. Clinical Review

    1. Top of page
    2. Original Contributions
    3. Basic Science Review
    4. Clinical Review
    5. Professional Affairs And Public Policy
    6. Editorial
    7. Selected Summaries
    1. Treatment of inflammatory bowel disease in childhood: Best available evidence (pages 34–58)

      Dr. Johanna C. Escher, Jan A. J. M. Taminiau, Edward E. S. Nieuwenhuis, Hans A. Büller and Richard J. Grand

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200301000-00006

  4. Professional Affairs And Public Policy

    1. Top of page
    2. Original Contributions
    3. Basic Science Review
    4. Clinical Review
    5. Professional Affairs And Public Policy
    6. Editorial
    7. Selected Summaries
  5. Editorial

    1. Top of page
    2. Original Contributions
    3. Basic Science Review
    4. Clinical Review
    5. Professional Affairs And Public Policy
    6. Editorial
    7. Selected Summaries
  6. Selected Summaries

    1. Top of page
    2. Original Contributions
    3. Basic Science Review
    4. Clinical Review
    5. Professional Affairs And Public Policy
    6. Editorial
    7. Selected Summaries
    1. Primum non nocere: Is it time to tumble the old pyramid and build a new one? (pages 71–72)

      Bruce E. Sands and Aaron Brzezinski

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200301000-00010

    2. Runs in the family (pages 72–73)

      Bruce E. Sands and Uma Mahadevan

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200301000-00011

    3. Searching for the crystal ball that will predict response to infliximab (pages 73–74)

      Bruce E. Sands, Shelly Johns and Miguel Regueiro

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200301000-00012

SEARCH

SEARCH BY CITATION